Clinical Trial Update: Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab [Phase 4]

View source ↗

Summary

Phase 4 trial updating etanercept treatment in patients with moderate to severe plaque psoriasis who lost response to adalimumab; study terminated with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Etanercept (etanercept)

Snippet

Sponsor: Amgen | Conditions: Psoriasis | Phase 4 | Status: TERMINATED | Results posted: 2016-06-27